NCT06190301View on ClinicalTrials.gov

RCT on Intralesional Rituximab Injection Versus ISRT in Ocular Adnexal MALT Lymphoma

NARecruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

January 11, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Primary Ocular Adnexal MALT Lymphoma
Interventions
DRUG

Rituximab

Intralesional Rituximab Injection

RADIATION

Involved Site Radiation Therapy

Involved Site Radiation Therapy

Trial Locations (2)

450001

RECRUITING

First Affiliated Hospital of Zhengzhou University, Zhengzhou

510060

RECRUITING

Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Zhongshan Ophthalmic Center, Sun Yat-sen University

OTHER